Myfembree · DIN 02541742 · 40 mg & 1 mg & 0.5 mg · tablet
General benefitMarketed · checked November 19, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
No interchangeable product listed in the Ontario extract
Myfembree · DIN 02541742
Manufacturer: Knight Therapeutics Inc.; listing date 2026-01-30
Health Canada: Marketed since 2026-05-19 · brand MYFEMBREE · ATC H01CC54 RELUGOLIX, ESTRADIOL AND NORETHISTERONE · form Tablet · route Oral · ingredients RELUGOLIX 40 MG, ESTRADIOL 1 MG, NORETHINDRONE ACETATE 0.5 MG · company Knight therapeutics inc. · schedule Prescription
Myfembree: Formulary list price $9.32 per unit (the source does not state the unit; exact figure $9.3150). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada); extract: Marketed October 28, 2025; live record preferred: Marketed May 19, 2026 (checked November 19, 2026) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02541742)
Source record
DIN 02541742: Myfembree
Raw flags: sec3=Y
Item: 681800021; group id 738; item number 1806; lccId None; manufacturer id KNT
Source form: Tab; strength: 40mg & 1mg & 0.5mg
Recorded listing: General benefit
Source prices (unrounded): $9.3150; ministry $9.3150
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02541742
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada); extract: Marketed October 28, 2025; live record preferred: Marketed May 19, 2026 (checked November 19, 2026) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=103029
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02541742
Shortage record checked October 6, 2026